Open Book Extracts (OBE) has appointed four strategic advisors to support and accelerate industry-specific research initiatives and boost its post-development commercialization efforts.
The newly appointed advisors are respected experts in their fields with experience as researchers, executives, and entrepreneurs.
Dave Wood, who most recently served as CEO of Captek, the largest dietary supplement softgel manufacturer in North America, will serve as nutraceutical advisor. Wood possesses more than 30 years of management experience with an emphasis on pharmaceutical-grade manufacturing, research and development, and licensing, with a deep background in the nutritional supplement sector.
Cosmeceutical advisors include Dr. Jeffrey Dover, MD, FRCPC, co-director of SkinCare Physicians of Chestnut Hill, a comprehensive facility specializing in dermatology, laser and cosmetic surgery, where he has been named as a Top Doctor in Boston for 16 years. Dr. Dover also serves as associate professor of Clinical Dermatology at Yale University School of Medicine, and associate professor of Dermatology at Brown Medical School, with research focus areas in Photomedicine, lasers in medicine, cosmetic laser surgery, and medical education. He is joined by Dr. Michael Singer, MD, PhD, a serial biotech executive and chief scientific officer at Cartesian Therapeutics, a clinical-stage biotechnology company and leader in mRNA-engineered cell therapies.
Veterinary advisor is Dr. Robert Silver, DVM, MS, a licensed and nationally renowned integrative veterinarian, and one of the leading experts on veterinary health and medical cannabis. He is the author of “Medical Marijuana and Your Pet” and has recently authored four chapters in two Springer-Nature textbooks on Veterinary Cannabis. Dr. Silver holds adjunct faculty positions at Lincoln Memorial University's College of Veterinary Medicine and the Chi University of Traditional Chinese Veterinary Medicine and is president-elect of the American College of Veterinary Botanical Medicine.
"Each appointee joining OBE from sectors outside the cannabis category is a testament to the broad appeal of the industry and the unique opportunity to make an impact through OBE," said Dave Neundorfer, co-founder and CEO of Open Book Extracts. "Bringing diverse skill sets and successful careers in pharmaceutical-grade manufacturing, consumer healthcare, gene therapies, veterinary medicine, cosmeceutical development, intellectual property and patent strategy, the advisors are already actively engaged in advancing OBE's vision of delivering innovative, research-backed products to lead the way for cannabinoid-enabled health and wellness.”